SAMSUNG PHARM. Co., LTD. (KRX: 001360)

Market Cap	174.03B
Revenue (ttm)	44.65B
Net Income (ttm)	-5.96B
Shares Out	94.12M
EPS (ttm)	-101.96
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	800,035
Open	1,760.00
Previous Close	1,765.00
Day's Range	1,757.00 - 1,838.00
52-Week Range	1,453.00 - 2,869.12
Beta	0.93
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About SAMSUNG PHARM. Co., LTD.

SAMSUNG PHARM. Co., LTD. manufactures and sells pharmaceutical products in South Korea. It offers prescription medicines, such as anticancer immunotherapy, antipyretic analgestic and antiinflammatory, antiobesity, hypotensive, antiarteriosclerotic, digestive organs, antophlegms, enzymes, ostepoposis, and transfusion agents, as well as skeletal muscle relaxants, anti-spastic, mixed vitamins, antibiotics, and others. The company also provides medicines for digestive system, medicines for liver disorder, medicines for circulation system, cold medi...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1929
• Employees: 240
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 001360

Financial Performance

In 2018, SAMSUNG PHARM. Co., LTD.'s revenue was 46.48 billion, an increase of 10.89% compared to the previous year's 41.92 billion. Losses were -2.08 billion, -72.47% less than in 2017.